{"id":70761,"date":"2023-08-12T18:39:39","date_gmt":"2023-08-12T13:09:39","guid":{"rendered":"http:\/\/finservwealth.com\/aurobindo-pharma-q1-results-net-profit-declines-22-5-to-rs-540-crore\/"},"modified":"2023-08-12T18:39:39","modified_gmt":"2023-08-12T13:09:39","slug":"aurobindo-pharma-q1-results-net-profit-declines-22-5-to-rs-540-crore","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/aurobindo-pharma-q1-results-net-profit-declines-22-5-to-rs-540-crore\/","title":{"rendered":"Aurobindo Pharma Q1 results: Net profit declines 22.5% to Rs 540 crore"},"content":{"rendered":"<p> Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said.<\/p><div id=\"finse-2222790341\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/results\/aurobindo-pharma-q1-results-net-profit-declines-225-to-rs-540-crore_17187341.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said. Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/results\/aurobindo-pharma-q1-results-net-profit-declines-225-to-rs-540-crore_17187341.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/results\/aurobindo-pharma-q1-results-net-profit-declines-225-to-rs-540-crore_17187341.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said. Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/results\/aurobindo-pharma-q1-results-net-profit-declines-225-to-rs-540-crore_17187341.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Revenue from operations came in at Rs 6,850.50 crore, up 10  percent from Rs 6,236 crore in the same quarter of the previous fiscal, the company said.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-70761","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/M\/Medicine_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/70761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=70761"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/70761\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=70761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=70761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=70761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}